Molina director receives 237-share equity award

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Stephen H. Lockhart received a stock award rather than making an open-market purchase. He was granted 237 shares of common stock on July 1, 2026 at a reference price of $232.55 per share under the company’s 2025 Equity Incentive Plan.

This grant represents one quarterly installment of an annual equity award valued at $220,000 for each director, with $55,000 granted on the first day of each quarter based on the closing share price that day. After this award, Lockhart directly holds 4,384 Molina Healthcare shares.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 1 txn

Insider Lockhart Stephen H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 4,384 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Key Figures

Shares granted: 237 shares Grant reference price: $232.55 per share Quarterly equity award value: $55,000 +2 more

5 metrics

Shares granted 237 shares Quarterly director equity award on July 1, 2026

Grant reference price $232.55 per share Closing price on July 1, 2026 used to size the grant

Quarterly equity award value $55,000 One quarter of the annual director equity award

Annual director equity award $220,000 Total annual equity compensation set for each director

Post-transaction holdings 4,384 shares Stephen H. Lockhart’s direct Molina Healthcare holdings after grant

Key Terms

2025 Equity Incentive Plan, annual equity award, Common Stock, Form 4

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Common Stock financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Stephen Lockhart report on this Form 4?

Stephen H. Lockhart reported receiving a stock grant of 237 Molina Healthcare shares. The award was issued on July 1, 2026 as part of his director compensation under the 2025 Equity Incentive Plan, not through an open-market share purchase.

How large is Stephen Lockhart’s latest Molina Healthcare (MOH) equity award?

The latest equity award to Stephen H. Lockhart was 237 shares of common stock. The grant was valued at $55,000, calculated using Molina Healthcare’s July 1, 2026 closing price of $232.55 per share as specified in the company’s director compensation structure.

What is Molina Healthcare’s annual equity compensation for directors like Stephen Lockhart?

Molina Healthcare set the annual equity award for each director at $220,000. One quarter, or $55,000, is granted on the first day of each quarter, with the share count determined using the company’s common stock closing price on that specific day.

At what price was Stephen Lockhart’s Molina Healthcare (MOH) stock grant calculated?

The July 1, 2026 grant was calculated using a share price of $232.55. This represents Molina Healthcare’s common stock closing price on that date and determined that 237 shares equaled the scheduled $55,000 quarterly equity award for the director.

How many Molina Healthcare (MOH) shares does Stephen Lockhart hold after this transaction?

After the reported grant, Stephen H. Lockhart directly owns 4,384 Molina Healthcare shares. This total reflects his position following the July 1, 2026 award of 237 common shares under the 2025 Equity Incentive Plan for directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lockhart Stephen H

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	4,384	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Stephen H. Lockhart.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)